Diagnostic Kit for Novel-Coronavirus(2019-nCoV) RNA (Isothermal Amplification-Real Time Fluorescence Assay)
Ongoing Challanges
The COVID-19 pandemic has affected the lives and daily routines of hundreds of millions of individuals worldwide, including their caregivers and families.
Continuous emergence of new variants (e.g., Omicron sublineages) that evade immunity and require updated vaccines, alongside the risk of recombinant variants, complicates surveillance.
There is a need for universal coronavirus vaccines, better antivirals, and strengthened surveillance to track variants and co-infections.
Product Overview
This kit is used for the in vitro qualitative detection of the novel coronavirus (SARS-CoV-2) ORF1ab and N genes in nasopharyngeal swabs, oropharyngeal swabs, sputum, and saliva samples from patients with suspected COVID-19 pneumonia, suspected clustered cases, and others requiring SARS-CoV-2 diagnosis.
Fast results obtained within 25 minutes
Designed to provide an accurate LOD: 200 copies/mL
Fully closed detection procedure effectively prevents cross-contamination
Clinical Value
Enables precise and timely treatment.
Facilitates Point-of-Care testing.
Breaks the limitations of testing scenarios and enhances surveillance capabilities.
